MiSight 1 Day Safety Post-Approval Study

July 6, 2026 updated by: CooperVision, Inc.
The purpose of this post-approval study is to confirm the safety of daily disposable soft contact lens wear among the intended patient population for the MiSight 1 Day lens in the US.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Detailed Description

This prospective post-approval study of safety in a US study population is to confirm the safety of MiSight 1 day lenses. Consecutive subjects receiving the MiSight 1 Day lens, who meet the inclusion criteria, will be prospectively offered to participate in the study. Additionally, safety data from the MiSight 1 Day Post-Approval Study for Effectiveness and Visual Symptoms (PAS001) will be used to supplement this safety study.

Study Type

Interventional

Enrollment (Estimated)

2400

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Markham, Ontario, Canada, L3R3P9
        • Dr. Kit Guan & Associates
      • Oakville, Ontario, Canada, L6M5A9
        • Abbey Eye Care
      • Toronto, Ontario, Canada, M2N 3A1
        • Optometry Professional Corporation
    • Arizona
      • Gilbert, Arizona, United States, 85297
        • Experts on Sight LLC.
    • Arkansas
      • Centerton, Arkansas, United States, 72719
        • Centerton Family Eyecare
    • California
      • Berkeley, California, United States, 94720
        • University of California, Berkeley University Eye Center
      • Cupertino, California, United States, 95014
        • Golden Vision Cupertino Optometry
      • Danville, California, United States, 94506
        • Boghossian Vision
      • Dublin, California, United States, 94568
        • Iron Horse Optometric Group
      • Fremont, California, United States, 94536
        • Capitol Eye Care Center Optometry
      • Irvine, California, United States, 92618
        • Irvine Eye Physicians and Surgeons Inc
      • Oakland, California, United States, 94607
        • Elsa Pao OD, Inc
      • San Jose, California, United States, 95118
        • Perfect Pair Optometry
      • San Jose, California, United States, 95120
        • Almaden Family Optometric Center
    • Colorado
      • Centennial, Colorado, United States, 80112
        • Children's Eye Physicians
    • Connecticut
      • Milford, Connecticut, United States, 06460
        • Eye Physicians & Surgeons, PC
    • Florida
      • Lake Worth, Florida, United States, 33467
        • Planet Vision Eyecare
      • Miami, Florida, United States, 33156
        • Marino Eye Care
      • Oviedo, Florida, United States, 32765
        • Vision Source Oviedo, INC
      • Sarasota, Florida, United States, 34239
        • Gulf Coast Eye Center
      • St. Johns, Florida, United States, 32259
        • Dau Family Eye Care
      • Weston, Florida, United States, 33331
        • Weston Contact Lens Institute LLC
    • Illinois
      • Chicago, Illinois, United States, 60611
        • Lurie Childrens
      • Chicago, Illinois, United States, 60657
        • Lyons Family Eye Care P.C.
      • Darien, Illinois, United States, 60561
        • Darien Eye Specialists
      • Glenview, Illinois, United States, 60025
        • Carillon Vision Care
    • Indiana
      • Carmel, Indiana, United States, 46032
        • Little Eyes Pediatric Eye Care
    • Maryland
      • Rockville, Maryland, United States, 20852
        • All Eyes on Rockville
    • Massachusetts
      • Wellesley, Massachusetts, United States, 02482
        • Wellesley Vision Group at Optical Design
    • Missouri
      • California, Missouri, United States, 65018
        • Missouri Eye Consultants - California
      • Des Peres, Missouri, United States, 63131
        • Center for Vision and Learning
    • New Jersey
      • Morristown, New Jersey, United States, 07960
        • Advocare Pediatric Eye Physicians
    • New York
      • The Bronx, New York, United States, 10467
        • Bronx Eye Associates
    • North Carolina
      • Apex, North Carolina, United States, 27502
        • Clarity Vision
      • Cary, North Carolina, United States, 27519
        • Cary Family Eye Care
    • Ohio
      • Chagrin Falls, Ohio, United States, 44023
        • Chagrin Valley Optometrists, Inc.
      • Pickerington, Ohio, United States, 43147
        • Pickerington Eye Care
    • Pennsylvania
      • State College, Pennsylvania, United States, 16801
        • Nittany Eye Associates, LLC
    • Texas
      • Beaumont, Texas, United States, 77706
        • Texas State Optical
      • Bellaire, Texas, United States, 77401
        • Bellaire Family Eye Care
      • Corpus Christi, Texas, United States, 78411
        • Drs. McIntyre, Garza, Avila and Jurica, Optometrists
      • Frisco, Texas, United States, 75034
        • Clarkson EyeCare KIDS
      • Plano, Texas, United States, 75024
        • Lone Star Vision Center
      • San Antonio, Texas, United States, 78258
        • Stone Oak Vision Source
    • Utah
      • Pleasant Grove, Utah, United States, 84062
        • Child & Family Eye Care Center
      • Salt Lake City, Utah, United States, 84111
        • Broadway Eye Clinic
      • Sandy City, Utah, United States, 84070
        • Invision Eye Health
    • Virginia
      • Williamsburg, Virginia, United States, 23185
        • Colonial Eye Care
    • Washington
      • Redmond, Washington, United States, 98052
        • Redmond Eye Clinic
    • West Virginia
      • Morgantown, West Virginia, United States, 26505
        • Spectrum Optical, PLLC

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

8 years to 12 years (Child)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Be between 8 and 12 years of age inclusive at the time of enrollment.
  2. Manifest Refraction - Spherical Equivalent Refractive Error (SERE) at baseline between -0.50 D and -7.00 D inclusive (at the corneal plane).
  3. Best-corrected visual acuity by manifest refraction of at least 20/25 bilaterally
  4. Free of ocular disease or abnormalities (including any corneal scar)
  5. The parent/guardian must be capable of comprehending the nature of the study and consent to the use and release of their child's de-identified health care encounter data to be used for purposes of this study. Assent will be obtained from the child in a manner specified by the IRB.
  6. Parent/Guardian must sign the Release of Medical Records associated with the outcomes of interest identified from claims data.
  7. Interested in wearing contact lenses for approximately 10 hours per day and 6 days per week.
  8. Possesses, or obtains prior to dispensing, wearable and visually functional (20/40 or better) eyeglasses.

Exclusion Criteria:

  1. Acute and subacute inflammation or infection of the anterior chamber of the eye.
  2. Any eye disease, injury, or abnormality that affects the cornea, conjunctiva, or eyelids.
  3. Severe insufficiency of lacrimal secretion (dry eyes).
  4. Corneal hypoesthesia (reduced corneal sensitivity), if not aphakic.
  5. Any systemic disease that may affect the eye or be exaggerated by wearing contact lenses.
  6. Allergic reactions of ocular surfaces or adnexa that may be induced or exaggerated by wearing contact lenses or use of contact lens solutions.
  7. Any active corneal infection (bacterial, fungal, or viral).
  8. If eyes are red or irritated.
  9. The patient is unable to follow lens handling and wear regimen or unable to obtain assistance to do so.
  10. In addition to the labeling contraindications, children who are under medication that would interfere with contact lens wear, or who are using any pharmaceuticals for control of myopia will not be included in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: MiSight 1 Day
Subjects will wear MiSight 1 day lenses for three years.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of Microbial Keratitis (MK)
Time Frame: 3 years
Incidence of Microbial Keratitis (MK) ≥ 1 mm
3 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of peripheral infiltrative keratitis/non-infectious ulcers
Time Frame: 3 years
Incidence of peripheral infiltrative keratitis/non-infectious ulcers ≤ 1 mm
3 years
Incidence of non-infectious infiltrative keratitis
Time Frame: 3 years
Incidence of non-infectious infiltrative keratitis ≤ 1 mm
3 years
Incidence of loss of best-corrected visual acuity
Time Frame: 3 years
Incidence of loss of best-corrected visual acuity ≥ 2 lines for any adjudicated adverse event.
3 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Kathryn Richdale, CooperVision International Limited (CVIL)

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 15, 2022

Primary Completion (Estimated)

March 2, 2030

Study Completion (Estimated)

June 30, 2030

Study Registration Dates

First Submitted

March 9, 2022

First Submitted That Met QC Criteria

March 9, 2022

First Posted (Actual)

March 17, 2022

Study Record Updates

Last Update Posted (Actual)

July 8, 2026

Last Update Submitted That Met QC Criteria

July 6, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • PAS002

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe